TCRT

Alaunos Therapeutics Inc

NASDAQ

Add Alert

TCRT

Alaunos Therapeutics Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

Monksdream PremiumMember

03/30/24 11:54 AM

Post #1,228

Re: #1,226: @Renee - TCRT: effective Feb. 1,2024 a one for 15

TCRT under $2

glenn1919

03/02/24 7:48 AM

Post #1,227

TCRT..................................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

Renee

01/30/24 9:53 AM

Post #1,226

TCRT: effective Feb. 1,2024 a one for 15 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php

BurgerKing82 Free

01/25/24 7:54 AM

Post #1,225

Re: #1,221: @Gatorhide - Would like to see an ATH.

What's the deal with this bio

glenn1919

01/13/24 8:57 AM

Post #1,224

Re: #1,222: @glenn1919 - TCRT.........................................https://stockcharts.com/h-sc/ui?s=T

TCRT..............................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

Gatorhide

01/12/24 10:10 AM

Post #1,223

LFG

glenn1919

01/06/24 8:03 AM

Post #1,222

TCRT.........................................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

Gatorhide

01/05/24 12:23 PM

Post #1,221

Would like to see an ATH.

subslover

10/26/23 4:29 PM

Post #1,220

Re: #1,219: @2020Benzo - Let’s pump this $.12 themed bottom stock we

The PUMP has begun

2020Benzo

09/17/23 1:02 AM

Post #1,219

Let’s pump this $.12 themed bottom stock we saw many $.12 runners AGRI PVLP LIFW MIMO AWIN why not this?

Monksdream PremiumMember

08/15/23 11:47 AM

Post #1,218

Re: #1,217: @bcapps66 - Opportunity or lost cause?

In my view, throwing more good money into a bad money situation amounts to gambling
We’re currently in a bull market for mature companies which is how I am spreading my money around

bcapps66

08/15/23 10:19 AM

Post #1,217

Re: #1,216: @Monksdream - TCRT new 52 week low

Opportunity or lost cause?

Monksdream PremiumMember

08/12/23 1:11 PM

Post #1,216

TCRT new 52 week low

Monksdream PremiumMember

08/07/23 3:01 PM

Post #1,215

TCRT new 52 week low

vpagano

10/06/22 11:57 PM

Post #1,214

Re: #1,213: @eddyimano - I can not find any article or info

They filed an 8-K:

https://www.bamsec.com/filing/119312522254857?cik=1107421

eddyimano

10/06/22 12:29 PM

Post #1,213

Re: #1,210: @howardriggin - Watch on Sept 30. Boom. To Uranus and beyond

I can not find any article or info from 9/30 presentations….

ollik78

09/26/22 4:48 PM

Post #1,212

3$+ this week

PennyPusher786 Free

09/26/22 4:41 PM

Post #1,211

Re: #1,209: @eddyimano - Thank you for asking, “UP 140%!” But because I

Lol... good for you my friend. Hope you all make some retirement money

howardriggin Free

09/26/22 3:28 PM

Post #1,210

Re: #1,208: @PennyPusher786 - How's that call option looking today?

Watch on Sept 30. Boom. To Uranus and beyond

eddyimano

09/26/22 3:27 PM

Post #1,209

Re: #1,208: @PennyPusher786 - How's that call option looking today?

Thank you for asking, “UP 140%!”

But because I bought at $0.65, expiring Oct. 21 $2.50 call before the drop, I am still down more than 30%, haha, but I am happy to see TCRT going back up!

Let’s gooooo!

PennyPusher786 Free

09/26/22 3:16 PM

Post #1,208

Re: #1,207: @eddyimano - Ouch, I got killed today. I bought

How's that call option looking today?

eddyimano

09/21/22 10:43 PM

Post #1,207

Re: #1,205: @carusso - Thank you, and sorry my slow reply. I regret

Ouch, I got killed today. I bought option call and the value became only half now…
Good luck everyone. I am still hoping for good presentation on 9/30/22. This needs to turn around.

eddyimano

09/19/22 9:11 PM

Post #1,206

Re: #1,205: @carusso - Thank you, and sorry my slow reply. I regret

I hope the presentation to be amazing on 9/30/22.

carusso

09/19/22 4:09 AM

Post #1,205

Re: #1,204: @eddyimano - My friend found this yesterday CRT's stock is

Thank you, and sorry my slow reply.

I regret I do not have the full subscription for private replies.

Is it still the case people like me can PM on Friday’s from 4-5 pm EST?

If so, let’s connect then.

You seem to have s good grasp of the field, at present. God knows this area of Science/Practice needs HELP.

eddyimano

09/16/22 10:00 PM

Post #1,204

Re: #1,201: @carusso - I hope so, Good Luck!

My friend found this yesterday

CRT's stock is down on heavy volume as a blog post from the husband of treated
Patient #2 reported that she has stopped therapy due to a mutation
(https://www.givesendgo.com/Woldt). While social media post are not company
press releases and in the vast majority of situations must be taken with a grain of
salt, there appears to be some validity here. With data from the objective response
(OR) seen in Patient #1 - who has lung cancer - about to be presented on
September 30, we are buyers of TCRT here on weakness. BUY.
Details from GoFundMe Blog
Now all of this from the unsolicited blog/link above. The woman has advanced
colon cancer which was targeted with P53 mutation from the TCR-T Library. She
started treatment late-Spring/early Summer that initially resulted in a 27% tumor
reduction. The mutation appears to have occurred after recent blood work was
performed at MD Andersen. A mutation in colon cancer is not unheard of as colon
cancer is known to often mutate when under pressure, i.e. chemotherapy.
Importantly and despite the setback in treatment, the patient is healthy enough to
resume chemotherapy and did not appear to suffer any platform-related side
effects that might have a negative read through to TCRT. Hence is the beauty of
the Alaunos' Sleeping Beauty kill switch and stopping the overactive immune
response before it gets out of control. As a reminder, all of this is unconfirmed
although the blog and its details appear legit.

Patient #1 Is Key

Most importantly, Alaunos recently confirmed that it has seen an objective partial
response (OR) in the first patient treated in the study. Patient #1 has non-small c
lung cancer, and had one prior line of adjuvant therapy following surgery and thre
prior lines of systemic therapy. The patient has a tumor with a KRAS G12D
mutation, not P53. The patient was treated at the first dose level with TCR-T cells.
an objective response was observed and has now cleared the 28-day safety
window. TCRT will report initial data from the study on Friday, September 30,
8:30am ET at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy
Conference.

A LOT MORE TO COME

In our view, the TCR-T platform has the ability to treat solid tumors with CAR-T
therapy, and the setback with Patient #2 will be a learning event for the Company.
The proprietary safety kill switch is a life saver in immuno-oncology. With only two
very late-stage patients having been treated, a 50% overall response rate (ORR)
would be more than acceptable.
The Company is advancing it's TCR-T Library Phase 1/2 trial targeting KRAS,
TP53 and EGFR mutations across six solid tumor indications, obviously the first
being lung, the second colorectal. We expect the upcoming detailed data from
Patient #1 will be positive and help the stock to regain its momentum. As we know
that different tumors respond differently and this is a very small sample size we are
dealing with; hence, the wild volatility in TCRT shares. However, we know for sure
that the platform has resulted in at least one objective response in a very advanced
lung cancer patient at the first dose, and that patient has been cleared by the FDA
to advance to the next dose. We are buyers on this weakness.

howardriggin Free

09/15/22 4:13 PM

Post #1,203

Re: #1,202: @dirtydozen911 - from td news feed 12:46 pm.

ONE PERSON? Starts a 50% share price drop? Something is f up here

dirtydozen911 Free

09/15/22 2:24 PM

Post #1,202

from td news feed 12:46 pm.
trading lower on circulation of a post on ...give.send.go... from a patient in tcr-t library phase1/2 trial.

didnt see the comment, but the patient must have had some side effects ...or worse , i would guess , for this stock to be taking such a beating

carusso

09/15/22 1:47 PM

Post #1,201

Re: #1,200: @eddyimano - Coming back down now. I hope my

I hope so, Good Luck!

eddyimano

09/15/22 1:40 PM

Post #1,200

Re: #1,198: @carusso - I’d say you did very well.

Coming back down now. I hope my feeling or intuition is right. Good luck to you.

howardriggin Free

09/15/22 1:39 PM

Post #1,199

Re: #1,196: @carusso - Not necessarily. It might have to do

Hmm

carusso

09/15/22 1:36 PM

Post #1,198

Re: #1,197: @eddyimano - Yeah, need to check broker bid/ask. I

I’d say you did very well.

eddyimano

09/15/22 1:28 PM

Post #1,197

Re: #1,195: @carusso - Yes, I see now - iHub Data feed

Yeah, need to check broker bid/ask. I tried to catch falling knife and I caught it. I hope I don’t cut my hands badly. I usually cut my hands really deep, haha.

carusso

09/15/22 1:26 PM

Post #1,196

Re: #1,192: @howardriggin - Down 50%? Then something very wrong. Whatever they

Not necessarily. It might have to do with their recent prospectus to raise $50M.

carusso

09/15/22 1:25 PM

Post #1,195

Re: #1,191: @eddyimano - No, I put limit order at $1.30, luckily

Yes, I see now - iHub Data feed and chart were not accurate when I asked that question, (it was showing 1.44 low). Also bid/ask not accurate as shown on iHub.

howardriggin Free

09/15/22 1:18 PM

Post #1,194

Re: #1,192: @howardriggin - Down 50%? Then something very wrong. Whatever they

Looks like data Tcrt was going to present on sept 30 might have leaked out as No good jmho. But down 50% when they have been up 13 months!! Think it’s gonna go to .50 soon

eddyimano

09/15/22 1:16 PM

Post #1,193

Re: #1,192: @howardriggin - Down 50%? Then something very wrong. Whatever they

They lost(-$0.25) last 12 month. That is why. I see to take advantage of this is great idea at $1.30. If much higher price, I am not sure short term.

howardriggin Free

09/15/22 1:13 PM

Post #1,192

Re: #1,189: @eddyimano - I saw that and it is not halted

Down 50%? Then something very wrong. Whatever they had to produce and get approval I think is scrubbed. Only reason for down $1.50 and halted. Simple. Oh well another loss.

eddyimano

09/15/22 1:12 PM

Post #1,191

Re: #1,190: @carusso - Did you mean 1.50?

No, I put limit order at $1.30, luckily it got filled. It went down as low as $1.26. I was thinking to sell, but I decide to keep to see what is coming in the future. I like to take chance.

carusso

09/15/22 1:10 PM

Post #1,190

Re: #1,189: @eddyimano - I saw that and it is not halted

Did you mean 1.50?

eddyimano

09/15/22 1:08 PM

Post #1,189

Re: #1,188: @carusso - Now down -51%!

I saw that and it is not halted anymore, so I added my position at $1.30. If the final stage results are good and approved, TRCT lost $0.25 last 12 month should be nothing, but just buying opportunity here. Future should be bright. We will see.

carusso

09/15/22 1:03 PM

Post #1,188

Re: #1,186: @eddyimano - What did just happen ? Down 33%?

Now down -51%!

eddyimano

09/15/22 12:47 PM

Post #1,187

Re: #1,186: @eddyimano - What did just happen ? Down 33%?

…

TCRT lost -$0.25 last 12 month. Time to buy more.

eddyimano

09/15/22 12:35 PM

Post #1,186

Re: #1,185: @howardriggin - Don’t think we see 4’s for another 4

What did just happen ? Down 33%?

howardriggin Free

09/12/22 4:48 PM

Post #1,185

Re: #1,184: @howardriggin - Been up last 6 months. I buy today.

Don’t think we see 4’s for another 4 weeks. Damn

howardriggin Free

09/12/22 2:23 PM

Post #1,184

Re: #1,183: @pennypauly - Looks like we will break into the 4’s today

Been up last 6 months. I buy today. Down. Bad luck. Still think great company

pennypauly PremiumMember

09/12/22 9:09 AM

Post #1,183

Looks like we will break into the 4’s today

bandit007

08/26/22 1:46 PM

Post #1,182

Re: #1,181: @bandit007 - We break 2.60 and it’s ok!! GL

Nice day today. Blue skies!

bandit007

08/25/22 2:07 PM

Post #1,181

Re: #1,180: @pennypauly - 2.30’s here

We break 2.60 and it’s ok!! GL

pennypauly PremiumMember

08/25/22 9:54 AM

Post #1,180

2.30’s here

pennypauly PremiumMember

08/15/22 10:58 AM

Post #1,179

Nice to see the 2’s broken

Older

Alaunos Therapeutics Inc (TCRT)

Followers	82	Posters	178
Posts (Today)	0	Posts (Total)	1228
Created	08/08/06	Type	Free
Moderators

http://www.ziopharm.com/

http://finance.yahoo.com/q/h?s=ZIOP

ZIOPHARM Oncology, Inc., a biopharmaceutical company, engages in the development and commercialization of a portfolio of in-licensed cancer drugs. It focuses primarily on the licensing and development of proprietary drug candidate families that are related to cancer therapeutics that are already on the market or in development. The company�s product candidates include ZIO-101, ZIO-201, and ZIO-301, which are in phase I and/or II studies. ZIO-101, organic arsenic is in a phase I/II trial in patients with advanced myeloma, as well as a phase I trial in advanced cancers; ZIO-201, stabilized isophosphoramide mustard is in a phase I/II trial in patients with advanced sarcoma, as well as in a phase I trials in advanced cancers; and ZIO-301, an anti-cancer agent that targets mitosis like the taxanes is in a phase I trial. ZIOPHARM was founded in 2003 and is based in New York, New York.

>